SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Utumi ER, Oliveira Sales MA, Shinohara EH, Takahashi A, Coracin FL, Rocha RG, et al. SAPHO syndrome with temporomandibular joint ankylosis: clinical, radiological, histopathological, and therapeutical correlations. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2008; 105: e6772.
  • 2
    Freyschmidt J, Sternberg A. The bullhead sign: scintigraphic pattern of sternocostoclavicular hyperostosis and pustulotic arthroosteitis. Eur Radiol 1998; 8: 80712.
  • 3
    Rutten HP, van Langelaan EJ. The SAPHO syndrome: a report of 2 patients. Acta Orthop Scand 2002; 73: 5903.
  • 4
    Vermaat M, De Schepper AM, Bloem JL. Sternocostoclavicular hyperostosis in Sapho-syndrome [abstract]. JBR-BTR 2005; 88: 1589.
  • 5
    Robinson CM, Jenkins PJ, Markham PE, Beggs I. Disorders of the sternoclavicular joint. J Bone Joint Surg Br 2008; 90B: 68596.
  • 6
    Amital H, Applbaum YH, Aamar S, Daniel N, Rubinow A. SAPHO syndrome treated with pamidronate: an open-label study of 10 patients. Rheumatology (Oxford) 2004; 43: 65861.
  • 7
    Guignard S, Job-Deslandre C, Sayag-Boukris V, Kahan A. Pamidronate treatment in SAPHO syndrome. Joint Bone Spine 2002; 69: 3926.
  • 8
    Just A, Adams S, Brinkmeier T, Barsegian V, Lorrenzen J, Schilling F, et al. Successful treatment of primary chronic osteomyelitis in SAPHO syndrome with bisphosphonates. J Dtsch Dermatol Ges 2008; 6: 65760.
  • 9
    Kopterides P, Pikazis D, Koufos C. Successful treatment of SAPHO syndrome with zoledronic acid. Arthritis Rheum 2004; 50: 29703.
  • 10
    Ringe JD, Faber H, Farahmand P. Rapid pain relief and remission of sternocostoclavicular hyperostosis after intravenous ibandronate therapy. J Bone Miner Metab 2006; 24: 8793.
  • 11
    Colina M, La Corte R, Trotta F. Sustained remission of SAPHO syndrome with pamidronate: a follow-up of fourteen cases and review of the literature. Clin Exp Rheumatol 2009; 27: 1125.
  • 12
    Olivieri I, Padula A, Ciancio G, Salvarani C, Niccoli L, Cantini F. Successful treatment of SAPHO syndrome with infliximab: report of two cases [letter]. Ann Rheum Dis 2002; 61: 3756.
  • 13
    Deutschmann A, Mache CJ, Koppany B, Zebedin D, Ring E. Successful treatment of chronic recurrent multifocal osteomyelitis with tumor necrosis factor-α blockage. Pediatr 2005; 116: 12313.
  • 14
    Wagner AD, Andresen J, Jendro MC, Hulsemann JL, Zeidler H. Sustained response to tumor necrosis factor α–blocking agents in two patients with SAPHO syndrome. Arthritis Rheum 2002; 46: 19658.
  • 15
    Sonozaki H, Furasowa S, Seki H, Kurosawa T, Tateishi A, Kabata K. Four cases with symmetrical ossifications between the clavicles and the first ribs on both sides. Kanto J Orthop Traumatol 1974; 5: 2447.
  • 16
    Kohler H, Uehlinger E, Kutzner J, Weihrauch TR, Wilbert L, Schuster R. Sterno-costo-clavicular hyperostosis: a hitherto undescribed entity. Dtsch Med Wochenschr 1975; 100: 151923. In German.
  • 17
    Chamot AM, Benhamou CL, Kahn MF, Beraneck L, Kaplan G, Prost A. Acne-pustulosis-hyperostosis-osteitis syndrome: results of a national survey. 85 cases. Rev Rhum Mal Osteoartic 1987; 54: 18796. In French.
  • 18
    Jahangier ZN, Jacobs JW, Bijlsma JW. SAPHO-syndrome: common denominator of some bone and skin diseases [review]. Ned Tijdschr Geneeskd 1997; 141: 7649. In Dutch.
  • 19
    Taylor HG, Dawes PT. Sterno-costo-clavicular hyperostosis. Brit J Clin Pract 1992; 46: 2768.
  • 20
    Kalke S, Perera SD, Patel ND, Gordon TE, Dasgupta B. The sternoclavicular syndrome: experience from a district general hospital and results of a national postal survey. Rheumatology (Oxford) 2001; 40: 1707.
  • 21
    Kasperczyk A, Freyschmidt J. Pustulotic arthroosteitis: spectrum of bone lesions with palmoplantar pustulosis. Radiology 1994; 191: 20711.
  • 22
    Sartoris DJ, Schreiman JS, Kerr R, Resnik CS, Resnick D. Sternocostoclavicular hyperostosis: a review and report of 11 cases. Radiology 1986; 158: 1258.
  • 23
    Hayem G. Valuable lessons from SAPHO syndrome. Joint Bone Spine 2007; 74: 1236.
  • 24
    Van Doornum S, Wicks I, Barraclough D, McColl G. SAPHO: rare or just not recognized? Semin Arthritis Rheum 2000; 30: 707.
  • 25
    Miyamoto M, Shirai Y, Nakayama Y, Gembun Y, Kitagawa Y, Nanbu A. A case report of synovitis acne pustulosis hyperostosis and osteitis syndrome presenting with spondylodiscitis. J Nippon Med Sch 2000; 67: 1917.
  • 26
    Davies AM, Marino AJ, Evans N, Grimer RJ, Deshmukh N, Mangham DC. SAPHO-syndrome: 20-year follow-up. Skeletal Radiol 1999; 28: 15962.
  • 27
    Tehlirian C. Round 7: synovitis-acne-pustulosis-hyperostosis osteomyelitis syndrome (SAPHO). Johns Hopkins Rheumatology Rounds Online. 2006. URL: http://www.hopkins-arthritis.org/physician-corner/cme/rheumatology-rounds/sapho_rheumrounds7.html.
  • 28
    Van der KlootWA, VertommenH, editors. The MPQ-DLV: a standard Dutch language version of the McGill Pain Questionnaire: background and instructions. Lisse (The Netherlands): Swets & Zeitlinger; 1989. In Dutch.
  • 29
    Kaptein A, van Korlaar IM, Scharloo M. The Brief Illness Perception Questionnaire. 2004. URL: http://www.uib.no/ipq/.
  • 30
    Kempen GI, Brilman EI, Heyink JW, Ormel J. Measuring general health by the MOS Short-Form General Health Survey (SF-20). Groningen (The Netherlands): Noordelijk Centrum voor Gezondheidsvraagstukken, Groningen University; 1995. In Dutch.
  • 31
    Pais M, McFarlane JD, Kroon HM. Osteitis with psoriasis. Ned Tijdschr Geneeskd 1994; 138: 13313. In Dutch.
  • 32
    European Organisation for Rare Diseases. The voice of 12,000 patients: experiences and expectations of rare disease patients on diagnosis and care in Europe. 2009. URL: http://www.eurordis.org/article.php3?id_article=1960&var_recherche=.
  • 33
    Listening to patients with rare diseases [editorial]. Lancet 2009; 373: 868.